Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Division of Pharmaceutics, Freeze Drying Focus Group, Erlangen 91058, Germany.
GILYOS GmbH, Friedrich-Bergius-Ring 15, Wuerzburg 97076, Germany.
J Pharm Sci. 2018 Aug;107(8):2005-2012. doi: 10.1016/j.xphs.2018.04.001. Epub 2018 Apr 9.
Controlling residual solvent levels is a major concern in pharmaceutical freeze-drying from co-solvent systems. This review provides an overview of the factors influencing this process and estimates their potential to reduce residual solvents in freeze-dried products. Decreased solvent contents are potentially correlated with the lower solid content, complete excipient crystallization, higher water solubility, and smaller molecular sizes of the solvent. Although no general rule can be derived for the selection of appropriate freezing conditions, the freezing stage appears to play a major role in subsequent volatile retention. In contrast, diverse secondary drying conditions do not appear to impact the amount of solvent retained in lyophilisates, and modification of this stage is thus not assumed to be expedient. Co-solvents are strongly entrapped in an amorphous product matrix as soon as the local moisture content decreases below a certain level. Thus, the moisture content in the dried product layer adjacent to the sublimation interface might be a key factor. Therefore, extension of the high moisture content period during the primary drying phase as well as a postlyophilization humidification of the dried products are presumably promising approaches to promote solvent release.
控制残留溶剂水平是共溶剂体系药物冷冻干燥的主要关注点。本综述概述了影响这一过程的因素,并估计了它们降低冷冻干燥产品中残留溶剂的潜力。溶剂含量的降低与固体含量较低、赋形剂完全结晶、更高的水溶性和更小的溶剂分子尺寸有关。虽然对于选择合适的冷冻条件不能得出一般规则,但冷冻阶段似乎在随后的挥发性保留中起主要作用。相比之下,不同的二次干燥条件似乎不会影响冻干物中保留的溶剂量,因此不认为可以对该阶段进行修改。一旦局部水分含量降至某一水平以下,共溶剂就会被强烈地困在无定形产品基质中。因此,靠近升华界面的干燥产品层中的水分含量可能是一个关键因素。因此,延长初级干燥阶段的高水分含量期以及对干燥产品进行冷冻干燥后的加湿,可能是促进溶剂释放的有前途的方法。